Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

Overview
Profile
Orthofix Medical Stock

Orthofix Medical Stock OFIX

OFIX
US68752M1080
A2NB0X

Price

12.53
Today +/-
-0.15
Today %
-1.43 %

Orthofix Medical stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Orthofix Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Orthofix Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Orthofix Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Orthofix Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Orthofix Medical Stock Price History

DateOrthofix Medical Price
8/8/202512.53 undefined
8/7/202512.71 undefined
8/6/202512.55 undefined
8/5/202512.32 undefined
8/4/202510.88 undefined
7/31/202510.77 undefined
7/30/202511.04 undefined
7/29/202511.36 undefined
7/28/202511.53 undefined
7/27/202511.40 undefined
7/25/202511.37 undefined
7/24/202511.25 undefined
7/23/202511.37 undefined
7/22/202511.11 undefined
7/21/202510.70 undefined
7/18/202510.63 undefined
7/17/202510.85 undefined
7/16/202510.72 undefined
7/15/202510.77 undefined
7/14/202510.95 undefined
7/11/202511.06 undefined
7/10/202511.37 undefined

Orthofix Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Orthofix Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Orthofix Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Orthofix Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Orthofix Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Orthofix Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Orthofix Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Orthofix Medical’s growth potential.

Orthofix Medical Revenue, EBIT and net profit per share

DateOrthofix Medical RevenueOrthofix Medical EBITOrthofix Medical Net Income
2027e938.55 M undefined-27.53 M undefined-35.4 M undefined
2026e871.62 M undefined-42.99 M undefined-54.55 M undefined
2025e829.06 M undefined-70.94 M undefined-92.77 M undefined
2024799.49 M undefined-60.28 M undefined-126 M undefined
2023746.64 M undefined-139.06 M undefined-151.4 M undefined
2022460.7 M undefined-11.7 M undefined-19.7 M undefined
2021464.5 M undefined5 M undefined-38.4 M undefined
2020406.6 M undefined-6.3 M undefined2.5 M undefined
2019460 M undefined15.4 M undefined-28.5 M undefined
2018453 M undefined30.1 M undefined13.8 M undefined
2017433.8 M undefined40.8 M undefined6.2 M undefined
2016409.8 M undefined35.5 M undefined3.1 M undefined
2015396.5 M undefined9.3 M undefined-2.8 M undefined
2014402.3 M undefined17.1 M undefined-8.5 M undefined
2013397.6 M undefined8 M undefined-28.8 M undefined
2012447.6 M undefined77.9 M undefined44.6 M undefined
2011435.5 M undefined56.5 M undefined-24.5 M undefined
2010460.6 M undefined66.3 M undefined44.2 M undefined
2009545.6 M undefined63.9 M undefined24.5 M undefined
2008519.7 M undefined31 M undefined-228.6 M undefined
2007490.3 M undefined59.1 M undefined11 M undefined
2006365.4 M undefined48.8 M undefined-7 M undefined
2005313.3 M undefined59.7 M undefined73.4 M undefined

Orthofix Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
1989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
101620283139527790104121131162177203286313365490519545460435447397402396409433453460406464460746799829871938
-60.0025.0040.0010.7125.8133.3348.0816.8815.5616.358.2623.669.2614.6940.899.4416.6134.255.925.01-15.60-5.432.76-11.191.26-1.493.285.874.621.55-11.7414.29-0.8662.177.103.755.077.69
70.0062.5070.0067.8667.7466.6763.4668.8371.1171.1571.9073.2873.4674.5874.8872.3873.1674.2573.6770.7174.6880.4378.1678.0873.0575.3778.2878.4878.5278.5978.0474.8875.2273.2665.1568.2165.7462.5758.10
71014192126335364748796119132152207229271361367407370340349290303310321340356359304349337486545000
-105679-19031412442125243473-711-2282444-2444-28-8-23613-282-38-19-151-125-92-54-35
---20.0016.6728.57-311.11--366.67-14.29266.67-52.2719.05-4.0041.67114.71-109.59-257.14-2,172.73-110.5383.33-154.55-283.33-163.64-71.43-75.00-250.00100.00116.67-315.38-107.14-2,000.00-50.00694.74-17.22-26.40-41.30-35.19
9.29.29.210.110.810.811.112.713.213.313.41414.714.714.71616.316.21717.117.217.918.219.418.718.518.818.518.518.918.919.419.720.136.7338.13000
---------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Orthofix Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Orthofix Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (k)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
19901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                     
1.10.215.217.220.573.64.179.750.534.348.831.425.963.825.925.114.613.313.633.231.128.936.863.739.681.269.669.796.387.850.733.1183.24
4.14.29.21112.819.7242732.739.842.246.154.770.775.380.7104.7108.9110.7129.8134.2146.5107.370.861.459.857.863.477.786.872.478.682.9128.1134.71
0000000.50.50000000000012.914.941.60000000000000
2.41.92.33.43.69.312.311.915.815.619.219.223.530.732.932.970.49491.294.684.691.283.472.759.857.663.381.376.882.484.683100.2222.17189.45
3.12.42.82.22.16.34.257.910.513.912.810.115.128.529.93352.958.148.964.592.188.992.76131.233.625.920.521.61720.122.337.0725.88
10.78.729.533.83942.344.648.563.475.6125.8112.4137.1147.9162.6207.3234280.9274.6299.5311.8404.6310.7265.1219212.3194.3251.8244.6260.5270.3269.5256.1420.44433.29
3.132.22.13.59.49.599.19.610.112.613.819.218.31925.333.432.738.745.552.153.854.448.552.348.945.142.864.668.562.465178.93157.04
001.73.24.80000.40.52.82.84.85.84.14.14.14.42.10000000000000000
00000000000000000000000000001.9121.41.10.30
43.73.299.56.36.462.42.54.34.14.265.770.665.6261.2230.353.547.641.537.57.397.25.37.510.551.954.160.552.747.4117.4998.8
0000045.852.549.545.146.647.256.758.8168.4178.9174.7313.1319.9182.6185.2176.5179.474.453.653.653.653.653.672.471.28471.371.3194.93194.93
7.13.50000001.91.90.40.32.26.26.43.224.716.815.719.528.721.926.829.964.776.867.844.45344.140.519.317.813.229.23
14.210.27.114.317.861.568.464.558.961.164.876.583.8265.3278.3266.6628.4604.8286.6291292.2290.9162.3146.9174188177.8153.6222235255.5207.1202.6504.87460.01
24.918.936.648.156.8103.8113113122.3136.7190.6188.9220.9413.2440.9473.9862.4885.7561.2590.5604695.5473412393400.3372.1405.4466.6495.5525.8476.6458.7925.32893.29
                                                                     
0.80.81111.31.31.31.31.31.41.41.41.51.61.61.61.71.71.71.81.81.91.81.91.91.81.81.91.91.9223.723.85
9.29.224.224.224.358.86363.363.263.966.768.550.98298.4106.7128.3157.3167.8177.2195.4214.3246.3216.7232.8232.1204.1220.6243.2271292.3314335746.45779.72
-6.4-1.44.812.521.51.71.24.318.631.576.397.3123.2147.9182.1255.5248.4258.229.654.198.397.3114.873.965.462.664.270.487.157.759.4211.3-150.14-276.14
-1-0.7-1.7-2.2-1.9-1.7-0.2-2.4-1.1-3.7-5.6-6.7-2.19.415.15.114.316.72.97.25.41.94.73.5-0.4-6.2-6.63.83.3-33.30-1.5-1.29-4.3
00000000030000000000000-100000000000010000
2.67.928.335.544.960.165.366.58293.3138.8160.5173.4240.8297.2368.9392.6433.9202240.2300.9315.2367.7295.9299.7290.4263.5296.6335.5327.6356.9337336.9598.73503.12
1.31.82.62.42.95.86.36.37.87.27.97.99.611.69.511.623.524.723.923.319.820.122.620.713.216.414.418.11819.923.126.527.658.3648.8
0.2000006.95.85.44.57.98.271010.37.24.39.330.64642.8126.735.5049.762.358.348.542.14345.347.144.289.1794.27
1.11.31.74.73.714.36.77.47.47.817.817.313.120.315.54429.827.315.313.29.69.84.149.73.53.310.812.825.821.73529.711.215.7424.8
9.1221.51.52.557.33.14.35.5470.10.10.10.18.71.92.23.81.30000000000000
1.91.10.20.20.23.73.63.62.34.54.50.70.411.110.115.23.33.33.33.37.517.500000000.30.52.60.71.960.76
13.66.26.58.88.326.328.530.42628.343.638.137.153.145.578.16173.3758883.5175.462.270.466.48283.579.485.984.9103.9105.983.7165.22168.63
8.34.70.71.1114.314.510.75.360.90.8099.167.20312.1294.6277.5249.1208.7191.220200000020.622.319.919.2111.64174.85
0000001.71.31.51.81.21.22.216.627.425.79575.94.56.18.19.811.51300000000000
0.20.31.233.91.90.70.73.43.33.43.43.53.73.71.21.57.92.16.92.8411.412.726.927.925.229.345.362.542.81418.949.7246.69
8.551.94.14.916.216.912.710.211.15.55.45.7119.498.326.9408.6378.4284.1262.1219.620542.945.726.927.925.229.345.383.165.133.938.1161.36221.54
22.111.28.412.913.242.545.443.136.239.449.143.542.8172.5143.8105469.6451.7359.1350.1303.1380.4105.1116.193.3109.9108.7108.7131.2168169139.8121.8326.59390.17
24.719.136.748.458.1102.6110.7109.6118.2132.7187.9204216.2413.3441473.9862.2885.6561.1590.3604695.6472.8412393400.3372.2405.3466.7495.6525.9476.8458.7925.32893.29
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Orthofix Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Orthofix Medical's financial health and stability.

Assets

Orthofix Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Orthofix Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Orthofix Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Orthofix Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
1989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
-105679-19031412442125243473-711-2282444-1842-28-8-23613-282-38-19
45000126666785614141628312222232022222020201824302929
000000000-501010-3-1-12-12-79-400-12-7-11021-2110240
-100-40-2-5-9-8-10-15-1-15-12-10-2512-41-44-32-20-3268-116333214-12-31-7-2819-24-29
00000027530445997752383413816-27143161938354683264226
222100011101000537271926161742100000000
0001033338810149141226311512172926188234000000
1363984246856182931271068212150426410675143443949327418-11
00000-2-2-3-3-3-5-5-6-7-5-12-12-12-27-20-22-26-25-28-29-18-27-18-16-16-22-24-20-24
000-2-7-4-34-3-38-10-12-14-16-155-11-12-354-27-13-22-2-31125-31-20-38-21-16-61-22-52-23-24
000-1-6-1-320011-5-7-7-9-15000-34206024-5153-1-1-10-30-440-28-20
0000000000000000000000000000000000
-1-2-10-110015-20-105-3-51102-33-62300-9-23-28-34-10-1900-200000000-2
1002100100-100-14-1712611151072025-3610-6-437711784
0-2-6140-116-10-115-2-190106-22-553074-17-29-40-13-137-38-2024-4633-103-30
00440-100000000-200-3-14-1-13-2326-2-1031-2-4-4-21-4-11-1
0000000000000000000000000000000000
0001423-13-302240-1615-15-537-370-10-1019-2-2726-2427-9-126-8-37
1.13.35.92.69.16.31.8-11.22.73.150.712.122.726.315.394.5-4.4-5.71.12816.139-18.637.332.515.726.422.133.29.150-2.3-36
0000000000000000000000000000000000

Orthofix Medical stock margins

The Orthofix Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Orthofix Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Orthofix Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Orthofix Medical's sales revenue. A higher gross margin percentage indicates that the Orthofix Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Orthofix Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Orthofix Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Orthofix Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Orthofix Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Orthofix Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Orthofix Medical Margin History

Orthofix Medical Gross marginOrthofix Medical Profit marginOrthofix Medical EBIT marginOrthofix Medical Profit margin
2027e68.28 %-2.93 %-3.77 %
2026e68.28 %-4.93 %-6.26 %
2025e68.28 %-8.56 %-11.19 %
202468.28 %-7.54 %-15.76 %
202365.13 %-18.62 %-20.28 %
202273.19 %-2.54 %-4.28 %
202175.26 %1.08 %-8.27 %
202074.94 %-1.55 %0.61 %
201978.11 %3.35 %-6.2 %
201878.68 %6.64 %3.05 %
201778.56 %9.41 %1.43 %
201678.55 %8.66 %0.76 %
201578.18 %2.35 %-0.71 %
201475.42 %4.25 %-2.11 %
201373.11 %2.01 %-7.24 %
201278.04 %17.4 %9.96 %
201178.07 %12.97 %-5.63 %
201080.37 %14.39 %9.6 %
200974.63 %11.71 %4.49 %
200870.75 %5.96 %-43.99 %
200773.69 %12.05 %2.24 %
200674.36 %13.36 %-1.92 %
200573.25 %19.06 %23.43 %

Orthofix Medical Stock Sales Revenue, EBIT, Earnings per Share

The Orthofix Medical earnings per share therefore indicates how much revenue Orthofix Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Orthofix Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Orthofix Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Orthofix Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Orthofix Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Orthofix Medical Revenue, EBIT and net profit per share

DateOrthofix Medical Sales per ShareOrthofix Medical EBIT per shareOrthofix Medical Earnings per Share
2027e24.61 undefined0 undefined-0.93 undefined
2026e22.86 undefined0 undefined-1.43 undefined
2025e21.74 undefined0 undefined-2.43 undefined
202420.97 undefined-1.58 undefined-3.3 undefined
202320.33 undefined-3.79 undefined-4.12 undefined
202222.92 undefined-0.58 undefined-0.98 undefined
202123.58 undefined0.25 undefined-1.95 undefined
202020.96 undefined-0.32 undefined0.13 undefined
201924.34 undefined0.81 undefined-1.51 undefined
201823.97 undefined1.59 undefined0.73 undefined
201723.45 undefined2.21 undefined0.34 undefined
201622.15 undefined1.92 undefined0.17 undefined
201521.09 undefined0.49 undefined-0.15 undefined
201421.75 undefined0.92 undefined-0.46 undefined
201321.26 undefined0.43 undefined-1.54 undefined
201223.07 undefined4.02 undefined2.3 undefined
201123.93 undefined3.1 undefined-1.35 undefined
201025.73 undefined3.7 undefined2.47 undefined
200931.72 undefined3.72 undefined1.42 undefined
200830.39 undefined1.81 undefined-13.37 undefined
200728.84 undefined3.48 undefined0.65 undefined
200622.56 undefined3.01 undefined-0.43 undefined
200519.22 undefined3.66 undefined4.5 undefined

Orthofix Medical business model

Orthofix Medical Inc is a leading global company in the field of orthopedic medical devices. The company is headquartered in Lewisville, Texas, USA and has been publicly traded since 1987. Orthofix's history dates back to the 1970s when it was founded as a small startup company. Since then, it has grown into a multinational company employing several thousand employees worldwide. Orthofix's business model is based on developing, manufacturing, and distributing orthopedic products and services that contribute to the restoration of mobility and quality of life for people with orthopedic conditions and injuries. The company offers a wide range of products ranging from implantable medical devices to conservative therapy options. Orthofix operates in three main divisions: 1. Spinal Implants and Biologics: This includes products such as intervertebral disc implants, interactive spinal fracture systems, and biological products to support bone healing. 2. Extremity Fixation: In this area, the company offers various implants for stabilizing fractures and joints, such as wrist supports or nail implants for stabilizing bone fractures in the arms and legs. 3. Orthofix PhysioStim: Orthofix PhysioStim is a non-invasive therapy option that supports bone and soft tissue healing. It is a portable device that generates electrical impulses and is used over an extended period of time. Orthofix's broad product portfolio also includes specialized products and services tailored to specific medical needs and groups. For example, the company offers some products specifically for children, such as the Pediatric Locking Nail System, a nail system for treating forearm and leg fractures in children. The company also provides products for animals, such as the VetLok External Fixation System, an implant system for stabilizing bone fractures in animals. Orthofix is committed to quality and product innovation to meet the needs of its customers and differentiate itself in a highly competitive market. The company continuously invests in research and development to develop new technologies and products that contribute to improving patient outcomes and support the work of doctors and surgeons. Overall, Orthofix Medical Inc is a leading company in the field of orthopedic medical devices, offering a wide range of products and services to support patients in restoring their mobility and quality of life. The company is committed to quality, innovation, and customer satisfaction, and invests in research and development to play a leading role in a competitive market. Orthofix Medical is one of the most popular companies on Eulerpool.com.

Orthofix Medical SWOT Analysis

Strengths

Orthofix Medical Inc. has several strengths that contribute to its competitive advantage in the market.

  • Diverse product portfolio: Orthofix offers a wide range of innovative medical devices and solutions, catering to different orthopedic needs and specialties.
  • Established brand: With years of experience and a strong reputation, Orthofix has built trust among healthcare professionals and patients alike.
  • Global presence: The company operates in multiple countries, allowing it to reach a larger customer base and tap into international markets.
  • Strong research and development capabilities: Orthofix invests heavily in R&D, enabling it to introduce cutting-edge technologies and stay ahead of competitors.

Weaknesses

Despite its strengths, Orthofix Medical Inc. also faces certain weaknesses that may hinder its growth and performance.

  • Dependence on specific markets: Orthofix is heavily reliant on the orthopedic market, making it vulnerable to fluctuations in this specific industry.
  • Regulatory challenges: Due to the nature of the medical device industry, Orthofix is subject to stringent regulations and compliance requirements, which can impede product development and approval timelines.
  • Limited diversification: The company's product range, although diverse within the orthopedic sector, may limit its ability to explore other potential markets for growth.

Opportunities

Orthofix Medical Inc. can capitalize on various opportunities to further expand its presence and improve its market position.

  • Emerging markets: The growing demand for orthopedic devices in developing economies presents significant opportunities for Orthofix to expand its customer base and increase sales.
  • Advancements in technology: Technological advancements and innovations in the medical field can open new possibilities for Orthofix to develop and introduce more advanced and effective products.
  • Increasing geriatric population: As the global population continues to age, there is a higher prevalence of orthopedic conditions, creating a larger market for Orthofix's solutions.

Threats

Orthofix Medical Inc. should be mindful of potential threats that may impact its operations and market position.

  • Intense competition: The orthopedic industry is highly competitive, with numerous players vying for market share. Orthofix needs to continuously innovate and differentiate its offerings to stay ahead.
  • Economic downturns: During economic downturns, healthcare spending may decrease, affecting the demand for orthopedic devices and potentially squeezing Orthofix's revenues.
  • Changing regulatory landscape: Regulatory changes can disrupt product development, approval processes, and operations, requiring Orthofix to adapt quickly to ensure compliance.

Orthofix Medical Revenue by Segment

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Orthofix Medical Revenue by Segment

Segmente20222021202020192018201720162011
Strategic Products-------573.16 M USD
Spine Products-------304.22 M USD
Orthopedics Products-------165.9 M USD
Stimulation Products-------160.44 M USD
Implants and Biologics Products-------143.78 M USD
Sports Medicine Products-------103.04 M USD
Divested Products-------5.83 M USD

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Orthofix Medical Revenue by Segment

Segmente20222021202020192018201720162011
Global spine-358.96 M USD321.74 M USD-----
Global Spine353.17 M USD-------
Global Orthopedics107.54 M USD105.52 M USD------
Spinal Implants---94.54 M USD91.66 M USD---
Global extremities--84.83 M USD-----

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Orthofix Medical Revenue by Segment

Segmente20222021202020192018201720162011
BioStim-----185.9 M USD176.56 M USD-
Global spine---357.22 M USD----
Biologics56.38 M USD56.42 M USD55.48 M USD-59.68 M USD62.72 M USD57.91 M USD-
Spine Reporting Segment-------304.22 M USD
Extremity fixation-----103.24 M USD102.68 M USD-
Bone Growth Therapies----195.25 M USD---
Orthopedics Reporting Segment-------165.9 M USD
Spine fixation-----81.96 M USD72.63 M USD-
Sports Medicine Reporting Segment-------108.87 M USD
Orthofix Extremities----106.45 M USD---
Global extremities---102.73 M USD----

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Orthofix Medical Revenue by Segment

Segmente20222021202020192018201720162011
Bone Growth Therapies187.25 M USD187.45 M USD171.4 M USD-----
Spinal Implants109.55 M USD115.09 M USD94.86 M USD-----
Biologics---65.5 M USD----

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Orthofix Medical Revenue by Segment

Segmente20222021202020192018201720162011
Bone Growth Therapies---197.18 M USD----

Orthofix Medical Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Orthofix Medical Revenue by Segment

DateBrazilCustomers and Distributors Based in EuropeFranceGermanyInternationalItalyOthersRepresents the geographic areas not specifically disclosedU.S.United Kingdom
20225.67 M USD-10.38 M USD11.57 M USD101.87 M USD19.1 M USD44.99 M USD-358.84 M USD10.17 M USD
20215.11 M USD-10.48 M USD13.72 M USD102.53 M USD20.19 M USD-42.5 M USD361.95 M USD10.55 M USD
20202.35 M USD57.7 M USD-11.94 M USD79.28 M USD18.73 M USD-39.12 M USD327.28 M USD7.15 M USD
20197.69 M USD69 M USD-12.69 M USD98.02 M USD19.56 M USD-47.99 M USD361.94 M USD10.09 M USD
20187.12 M USD69 M USD-11.61 M USD97.69 M USD19.33 M USD-50.9 M USD355.35 M USD8.73 M USD
201710.36 M USD57 M USD---17.06 M USD-52.54 M USD345.15 M USD8.73 M USD
201611.33 M USD60 M USD---16.66 M USD-54.56 M USD316.87 M USD10.36 M USD
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Orthofix Medical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Orthofix Medical historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Orthofix Medical shares outstanding

The number of shares was Orthofix Medical in 2024 — This indicates how many shares 38.134 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Orthofix Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Orthofix Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Orthofix Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Orthofix Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Orthofix Medical.

Orthofix Medical latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2025-0.5 0.13  (126.01 %)2025 Q2
3/31/2025-0.4 -0.08  (80.19 %)2025 Q1
12/31/2024-0.05 0.02  (139.22 %)2024 Q4
9/30/2024-0.15 0.07  (145.75 %)2024 Q3
6/30/2024-0.2 0.05  (125.36 %)2024 Q2
3/31/2024-0.34 -0.13  (61.76 %)2024 Q1
12/31/2023-0.08 0.02  (125.71 %)2023 Q4
9/30/2023-0.21 0.07  (132.88 %)2023 Q3
6/30/2023-0.48 0.02  (104.15 %)2023 Q2
3/31/2023-0.52 -0.1  (80.78 %)2023 Q1
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the Orthofix Medical stock

Eulerpool World ESG Rating (EESG©)

38/ 100

🌱 Environment

29

👫 Social

33

🏛️ Governance

52

Environment

Scope 1 - Direct Emissions
669
Scope 2 - Indirect emissions from purchased energy
2,619
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
3,288
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees49
Percentage of women in management
Percentage of Asian employees13
Share of Asian management8
Percentage of Hispanic/Latino employees17
Hispano/Latino Management share8
Percentage of Black employees8
Black Management Share5
Percentage of white employees56
White Management Share73
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Orthofix Medical shareholders

%
Name
Stocks
Change
Date
11.14938 % Engine Capital Management, LP4,251,671510,2815/7/2025
9.68945 % Rubric Capital Management LP3,694,94603/31/2025
7.77265 % Armistice Capital LLC2,964,000-36,0003/31/2025
7.23424 % BlackRock Institutional Trust Company, N.A.2,758,6843,7583/31/2025
6.50789 % Paradigm Capital Management, Inc.2,481,700-4,2003/31/2025
6.25824 % Juniper Investment Company, LLC2,386,500249,1264/9/2025
5.69567 % The Vanguard Group, Inc.2,171,97054,5283/31/2025
3.47635 % Emerald Advisers LLC1,325,662-5173/31/2025
2.48652 % Boone Capital Management LLC948,202-109,1113/31/2025
2.26955 % Geode Capital Management, L.L.C.865,46423,8273/31/2025
1
2
3
4
5
...
10

Orthofix Medical Executives and Management Board

Mr. Wayne Burris

(69)
Orthofix Medical Independent Director
Compensation 539,703

Mr. Jason Hannon

(51)
Orthofix Medical Independent Director
Compensation 376,249

Mr. Michael Paolucci

(64)
Orthofix Medical Independent Director
Compensation 376,249

Mr. John Henneman

(62)
Orthofix Medical Independent Director
Compensation 355,416

Ms. Shweta Maniar

(40)
Orthofix Medical Independent Director
Compensation 355,416
1
2
3
4

Orthofix Medical Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Ascendis Health Stock
Ascendis Health
SupplierCustomer-0,45-0,61-0,340,22-0,22-0,02
MTS Systems Corporation Stock
MTS Systems Corporation
SupplierCustomer-0,56-0,340,010,42
1

Most common questions regarding Orthofix Medical

What values and corporate philosophy does Orthofix Medical represent?

Orthofix Medical Inc represents the values of innovation, integrity, and patient-centricity. With a corporate philosophy deeply rooted in improving patients' lives, Orthofix Medical Inc is committed to developing and providing innovative orthopedic solutions. The company strives to maintain the highest standards of integrity and ethical conduct in all its operations. Through its cutting-edge technologies and dedication to research and development, Orthofix Medical Inc aims to deliver advanced medical devices and therapies that meet the unique needs of patients worldwide.

In which countries and regions is Orthofix Medical primarily present?

Orthofix Medical Inc is primarily present in countries and regions worldwide. The company operates in North America, Europe, Asia-Pacific, Latin America, and the Middle East. With a global presence, Orthofix Medical Inc has established a strong market position and serves patients and healthcare professionals in multiple countries and regions.

What significant milestones has the company Orthofix Medical achieved?

Orthofix Medical Inc has achieved significant milestones throughout its history. One notable achievement is the company's development of innovative medical devices and solutions for orthopedic and spine conditions. Additionally, Orthofix Medical Inc has successfully expanded its global presence, reaching healthcare professionals and patients worldwide. The company has also demonstrated its commitment to research and development, continuously introducing advanced technologies and treatments in the orthopedic field. Moreover, Orthofix Medical Inc has made strategic acquisitions and partnerships, further enhancing its product portfolio and market position. These milestones showcase Orthofix Medical Inc's dedication to improving patient outcomes and advancing the field of orthopedics.

What is the history and background of the company Orthofix Medical?

Orthofix Medical Inc. is a renowned medical device company with a rich history and background. Established in 1987, Orthofix has been dedicated to advancing orthopedic solutions and improving patient outcomes. With its headquarters in Lewisville, Texas, the company operates through various business segments, including Spinal Implants, Biologics, and External Fixation. Orthofix is committed to delivering innovative and high-quality products that help patients regain mobility and improve their quality of life. The company has a global presence and serves healthcare providers and patients worldwide. With its strong focus on research and development, Orthofix continues to shape the future of orthopedic care.

Who are the main competitors of Orthofix Medical in the market?

The main competitors of Orthofix Medical Inc in the market include Stryker Corporation, Zimmer Biomet Holdings Inc, DJO Global, Inc, and Medtronic PLC.

In which industries is Orthofix Medical primarily active?

Orthofix Medical Inc is primarily active in the healthcare industry, specifically focusing on orthopedic medical devices. With a strong commitment to improving patient mobility and quality of life, Orthofix offers a wide range of innovative products and solutions in spine fixation, bone growth stimulation, and biologics. Their expertise in orthopedics allows them to serve various healthcare professionals, including surgeons, physicians, and hospitals worldwide. Orthofix Medical Inc's extensive experience and dedication to advancing orthopedic care make them a key player in the industry, providing valuable solutions for patients and healthcare providers alike.

What is the business model of Orthofix Medical?

The business model of Orthofix Medical Inc. revolves around providing innovative medical solutions for the orthopedic and spine markets. The company focuses on developing, manufacturing, and marketing advanced medical devices and non-invasive orthopedic solutions. Orthofix Medical Inc. aims to improve patients' quality of life by offering technologically advanced products and therapies that aid in the treatment of various musculoskeletal conditions. They strive to deliver exceptional patient outcomes by combining industry-leading technology, clinical expertise, and evidence-based medicine. Orthofix Medical Inc. is committed to driving innovation, advancing patient care, and solidifying its position as a leading player in the orthopedic medical device industry.

What is the P/E ratio of Orthofix Medical 2025?

The Orthofix Medical P/E ratio is -5.15.

What is the P/S ratio of Orthofix Medical 2025?

The Orthofix Medical P/S ratio is 0.58.

What is the Quality Investing of Orthofix Medical?

The Quality Investing for Orthofix Medical is 3/10.

What is the revenue of Orthofix Medical 2025?

The expected Orthofix Medical revenue is 829.06 M USD.

How high is the profit of Orthofix Medical 2025?

The expected Orthofix Medical profit is -92.77 M USD.

What is the business model of Orthofix Medical

Orthofix Medical Inc is a globally leading medical technology company specializing in innovative orthopedic products in the global market. The company is headquartered in Lewisville, Texas, and has offices in over 50 countries. Orthofix Medical Inc specializes in providing high-quality solutions for complex orthopedic problems. Orthofix Medical consists of four main business areas: Extremities, Spine, Biologics, and International Operations. The Extremities division focuses on manufacturing products and instruments that target wrist and elbow surgery. The Spine division produces solutions for a variety of back problems, including herniated discs, scoliosis, and other complications. Biologics produces biological products that promote natural body regeneration and are suitable for use in orthopedic surgery. The International division supports the businesses that Orthofix Medical Inc operates in Europe, Asia, Latin America, and other regions of the world. Orthofix Medical Inc offers a wide range of products, including orthopedic implants, surgical instruments, bio-implants, and biological allografts. The company is a leader in developing solutions for bone regeneration and arthroscopic surgery. Among Orthofix Medical Inc's most well-known products are the M6-C core replacement, Octopus leg holder, and Trinity-ELITE bone replacement. In addition to its core competency of manufacturing high-quality orthopedic products, Orthofix Medical also offers innovative services. Orthofix Medical Inc provides its customers with training, certification programs, technical support, and consultation. Supporting physicians and clinics is an important part of Orthofix Medical's business philosophy. The business strategy of Orthofix Medical Inc aims to promote company growth through organic expansion and strategic acquisitions of companies operating in the fields of orthopedics, biology, and surgery. The company continuously invests in research and development to develop innovative solutions to address complex orthopedic challenges. Orthofix Medical Inc is also committed to high social and environmentally-friendly standards. The company follows a proactive environmental policy and strives to utilize resources efficiently and reduce waste. Orthofix Medical's corporate responsibility is also evident in its support of nonprofit organizations and its employees' involvement in supporting social projects. Overall, Orthofix Medical Inc has taken a leading role in the orthopedic industry by offering innovative products and services that help clinics and physicians address complex orthopedic problems. The company is committed to promoting its growth through continuous innovation and a proactive commitment to social and environmental responsibility.

What is the Orthofix Medical dividend?

Orthofix Medical pays a dividend of 0 USD distributed over payouts per year.

How often does Orthofix Medical pay dividends?

The dividend cannot currently be calculated for Orthofix Medical or the company does not pay out a dividend.

What is the Orthofix Medical ISIN?

The ISIN of Orthofix Medical is US68752M1080.

What is the Orthofix Medical WKN?

The WKN of Orthofix Medical is A2NB0X.

What is the Orthofix Medical ticker?

The ticker of Orthofix Medical is OFIX.

How much dividend does Orthofix Medical pay?

Over the past 12 months, Orthofix Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Orthofix Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Orthofix Medical?

The current dividend yield of Orthofix Medical is .

When does Orthofix Medical pay dividends?

Orthofix Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Orthofix Medical?

Orthofix Medical paid dividends every year for the past 0 years.

What is the dividend of Orthofix Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Orthofix Medical located?

Orthofix Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Orthofix Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Orthofix Medical from 8/9/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/9/2025.

When did Orthofix Medical pay the last dividend?

The last dividend was paid out on 8/9/2025.

What was the dividend of Orthofix Medical in the year 2024?

In the year 2024, Orthofix Medical distributed 0 USD as dividends.

In which currency does Orthofix Medical pay out the dividend?

The dividends of Orthofix Medical are distributed in USD.

All fundamentals about Orthofix Medical

Our stock analysis for Orthofix Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orthofix Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.